Multiple drugsQT prolongation (first report with gliquidone and dulaglutide) and type I second degree atrioventricular block: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1816卷 / 1期

关键词：

D O I：

10.1007/s40278-020-81872-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：237 / 237

相关论文

共 50 条

[1] BisoprololAtypical type I second degree atrioventricular block: case report
Reactions Weekly, 2020, 1821 (1) : 58 - 58
[2] Multiple drugsQT prolongation: case report
Reactions Weekly, 2022, 1891 (1) : 217 - 217
[3] Multiple drugsQT prolongation: case report
Reactions Weekly, 2024, 2023 (1) : 292 - 292
[4] Multiple drugsQT interval prolongation: case report
Reactions Weekly, 2017, 1680 (1) : 241 - 241
[5] Multiple drugsExacerbation of second-degree atrioventricular block to complete atrioventricular block: case report
Reactions Weekly, 2017, 1661 (1) : 231 - 231
[6] AtazanavirQT prolongation and first-degree atrioventricular block with ventricular tachycardia: case report
Reactions Weekly, 2013, 1453 (1) : 10 - 10
[7] Multiple drugsQT-interval prolongation: case report
Reactions Weekly, 2018, 1726 (1) : 244 - 244
[8] Multiple drugsQT prolongation and drug resistance: case report
Reactions Weekly, 2023, 1974 (1) : 255 - 255
[9] FingolimodMobitz type II second degree atrioventricular block followed by a third-degree atrioventricular block: case report
Reactions Weekly, 2019, 1784 (1) : 124 - 124
[10] FingolimodType 2 second degree atrioventricular block: case report
Reactions Weekly, 2021, 1883 (1) : 168 - 168

← 1 2 3 4 5 →